IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $711,118 | -33.6% | 111,286 | -0.5% | 0.01% | -40.0% |
| Q3 2022 | $1,071,000 | -24.5% | 111,850 | -13.0% | 0.01% | -9.1% |
| Q2 2022 | $1,419,000 | -24.6% | 128,551 | +13.6% | 0.01% | 0.0% |
| Q1 2022 | $1,883,000 | -5.7% | 113,113 | +8.1% | 0.01% | +10.0% |
| Q4 2021 | $1,997,000 | -15.0% | 104,596 | +9.8% | 0.01% | -28.6% |
| Q3 2021 | $2,350,000 | -7.9% | 95,299 | -2.8% | 0.01% | -6.7% |
| Q2 2021 | $2,551,000 | -9.9% | 98,060 | +9.7% | 0.02% | -21.1% |
| Q1 2021 | $2,831,000 | -12.1% | 89,422 | +28.9% | 0.02% | -5.0% |
| Q4 2020 | $3,220,000 | +18.3% | 69,398 | -16.0% | 0.02% | 0.0% |
| Q3 2020 | $2,721,000 | -12.0% | 82,641 | -26.6% | 0.02% | -16.7% |
| Q2 2020 | $3,091,000 | – | 112,602 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |